The pancreas can turn on itself when enzymes activate too early

Science · Published 25 October 2026 Swipe more like this →

In short: Imagine an organ designed to break down food suddenly begins digesting its own tissue. Acute pancreatitis is a serious inflammatory condition where this internal malfunction causes severe pain and potential organ failure. Understanding its mechanics reveals why it remains one of the most challenging conditions to treat with specific medication.

Acute pancreatitis occurs when digestive enzymes become active prematurely within the pancreas rather than in the small intestine. This leads to a cascade of inflammation, enzyme activation, and tissue damage. Key drivers in this pathogenesis include pancreatic intracellular calcium overload, mitochondrial impairment, and systemic inflammatory responses. While many cases are manageable, moderately severe forms can lead to fluid or necrotic collections, which carry substantial morbidity. In its most severe form, persistent organ failure can result in significant mortality.

Diagnosis typically requires meeting two of three criteria: upper abdominal pain, serum amylase or lipase levels at least three times the upper limit of normal, and specific findings on cross-sectional imaging. Common triggers include gallstones and ethanol consumption, though hypertriglyceridaemia and certain drugs are also notable causes. Clinicians use a battery of tests—including full blood counts, renal and liver function tests, glucose, calcium, and transabdominal ultrasound—to assess the patient's status and identify complications like infections.

Currently, there is no internationally licensed drug specifically designed to treat acute pancreatitis or prevent its complications. Management focuses on supportive care: intravenous fluid resuscitation, analgesia (pain relief), and enteral nutrition. If an infection is present, antibiotics are administered. For severe cases involving local complications, patients may require specialist intervention such as drainage or necrosectomy. Because the disease can progress to chronic pancreatitis—which increases the risk of pancreas cancer—proactive long-term management is essential for many patients.

Most individuals with acute pancreatitis begin to improve within a week and are discharged from the hospital in 5 to 10 days. However, because it is not considered a self-limiting disease, clinical trials for new or repurposed drugs are vital. These efforts aim to move beyond supportive care toward targeted therapies that address the underlying cellular mechanisms of the disease.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• In pancreatitis, the body's own digestive enzymes turn against the pancreas
• One gland is ninety-nine percent digestive, one percent hormonal
• The internal health coach managing your metabolism and digestion
• Your pancreas hides a tiny, vital organ that regulates your body's energy supply
• Understanding the dual role of the pancreas in digestion and glucose regulation
• Understanding the mechanics of acute tonsillitis and its treatment
• Why simple rehydration is a global lifeline for children
• The shift toward proactive screening for pre-symptomatic diabetes
• When a simple flap of tissue becomes a life-threatening airway emergency
• When the adrenal glands fail to sustain the body's balance
• One label, three distinct crises: understanding Acute Coronary Syndrome
• Why you cannot simply add fractions with different denominators

More in Science · Latest · A–Z · All topics